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Abstract
Background: Basic trainees in the US military have historically been vulnerable to respiratory infections. Adenovirus
and influenza are the most common etiological agents responsible for febrile respiratory illness (FRI) among
trainees and present with similar clinical signs and symptoms. Identifying demographic and clinical factors
associated with the primary viral pathogens causing FRI epidemics among trainees will help improve differential
diagnosis and allow for appropriate distribution of antiviral medications. The objective of this study was to
determine what demographic and clinical factors are associated with influenza and adenovirus among military
trainees.
Methods: Specimens were systematically collected from military trainees meeting FRI case definition (fever ≥38.0°C
with either cough or sore throat; or provider-diagnosed pneumonia) at eight basic training centers in the USA.
PCR and/or cell culture testing for respiratory pathogens were performed on specimens. Interviewer-administered
questionnaires collected information on patient demographic and clinical factors. Polychotomous logistic regression
was employed to assess the association between these factors and FRI outcome categories: laboratory-confirmed
adenovirus, influenza, or other FRI. Sensitivity, specificity, positive and negative predictive value were calculated for
individual predictors and clinical combinations of predictors.
Results: Among 21,570 FRI cases sampled between 2004 and 2009, 63.6% were laboratory-confirmed adenovirus
cases and 6.6% were laboratory-confirmed influenza cases. Subjects were predominantly young men (86.8% men;
mean age 20.8 ± 3.8 years) from Fort Jackson (18.8%), Great Lakes (17.1%), Fort Leonard Wood (16.3%), Marine Corps
Recruit Depot (MCRD) San Diego (19.0%), Fort Benning (13.3%), Lackland (7.5%), MCRD Parris Island (8.7%), and Cape
May (3.2%). The best multivariate predictors of adenovirus were the combination of sore throat (odds ratio [OR],
2.94; 95% confidence interval [CI], 2.66–3.25), cough (OR, 2.33; 95% CI, 2.11–2.57), and fever (OR, 2.07; 95% CI, 1.90–2.26)
with a PPV of 77% (p≤ .05). A combination of cough, fever, training week 0–2 and acute onset were most predictive of
influenza (PPV =38%; p≤ .05).
Conclusions: Specific demographic and clinical factors were associated with laboratory-confirmed influenza and
adenovirus among military trainees. Findings from this study can guide clinicians in the diagnosis and treatment of
military trainees presenting with FRI.
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Background
Historically, military basic trainees have been vulnerable
to severe epidemics of febrile respiratory illness (FRI)
[1,2]. Several factors predispose military trainees to the
spread respiratory infections, including crowded living
conditions and stressful work environments. The epi-
demiology and pathogens causing FRI among military
trainees is unique and differs from the civilian set-
ting [3]. Training populations are primarily prone to
outbreaks caused by adenovirus and influenza, which
often co-circulate and present with similar clinical
signs and symptoms [4].
In the presence of an epidemic, it is generally accept-
able to make a reasonable diagnosis based on clinical
signs and symptoms until laboratory confirmation can
be obtained. It is still debatable whether specific demo-
graphic and clinical symptoms can be used to distinguish
among respiratory pathogens. A few studies have identi-
fied clinical predictors for influenza in civilian and
military populations [5-9]. However, few studies have fo-
cused on other respiratory pathogens like adenovirus
that have caused substantial morbidity among military
trainees [10,11].
Adenovirus infections have caused significant morbid-
ity among US military trainees since the virus was
discovered in the1950s. With interrupted training sched-
ules, high morbidity, and the occasional death, it has
proved to be costly to the US Government [12,13]. Live
oral vaccines against types 4 and 7 adenovirus were
developed in the late 1960s and were successful in redu-
cing FRI rates and adenoviral morbidity after their intro-
duction in 1971. However, the sole vaccine manufacturer
stopped production in 1996, and adenovirus returned to
US recruit training centers and commands (RTCs) at
pre-vaccine levels after vaccine supplies were depleted in
1999. The clinical presentation of adenovirus-associated
FRI has been described as more severe than non–adeno-
virus-associated FRI, particularly when it is a novel
strain in which there is little to no immunity [14].
Adenoviruses cases present with higher temperatures
and have an increased number of cases with a cough and
sore throat compared with non–adenovirus-associated
FRI cases [14].
FRI infections present with a wide range of clinical
features. Identifying demographic and clinical factors
associated with the primary viral pathogens causing FRI
epidemics among military trainees will help improve
differential diagnosis, allow for appropriate distribution
of antiviral medications, and ultimately improve troop
readiness. The objective of this study was to determine
what demographic and clinical factors are associated
with influenza and adenovirus among military trainees
at RTCs in an effort to aid clinical diagnosis when
laboratory confirmation is not available.
Methods
Study population
Since 1996, the Naval Health Research Center (NHRC)
has conducted ongoing laboratory-based surveillance
FRI at eight basic training centers across the United
States: Fort Benning Army Training Center, Georgia;
Fort Jackson Army Training Center, South Carolina; Fort
Leonard Wood Army Training Center, Missouri; Lackland
Air Force Base, Texas; Great Lakes Naval Training Com-
mand, Illinois; Marine Corps Recruit Depots (MCRDs) San
Diego, California, and Parris Island, South Carolina; and
Cape May Coast Guard Training Center, New Jersey.
Length of basic training varies throughout branches of mili-
tary service: 10 weeks for the Army, 7 weeks Navy, 8 weeks
Air Force, 12 weeks Marine Corps, and 8 weeks Coast
Guard. In support of surveillance, military basic trainees
from these training sites meeting case definition for FRI
(fever ≥38.0°C with either cough or sore throat; or
provider-diagnosed pneumonia) were recruited for
the study. All subjects provided informed consent. This
study was approved by the Naval Health Research
Center (NHRC) Institutional Review Board (protocol
NHRC.1999.0002).
Specimen and data collection
Throat and nasal swabs and clinical data were systemat-
ically collected from consenting US military trainees
meeting the case definition for FRI. Each training site
except for Cape May had a trained research assistant
dedicated to enrolling subjects in the study and collect-
ing clinical specimens. Sampling of a maximum ranging
from 10 to 20 recruits per site per week was performed.
Subjects were systematically selected from trainees pre-
senting to their local clinic meeting FRI case definition.
Trainees were tracked throughout the entirety of their
training, with the exception of MCRD San Diego where
trainees left for Camp Pendleton for weeks 4 through 7
of training. Trainees awaiting the start of training were
assigned to training week 0.
Questionnaires administered by research assistants
(corpsmen at Cape May) collected information on pa-
tient demographic and clinical factors, including age,
sex, number of days since symptoms began, number of
visits to sick call during illness, diagnosis of pneumonia,
history of asthma, smoking history (pack-years), history
of influenza vaccination, week of training, and experi-
ence of any of the following symptoms during his or her
current illness: sore throat, cough, shortness of breath,
nasal congestion, headache, conjunctivitis, body aches,
and nausea or vomiting. The patient’s oral temperature
was abstracted from the medical record or taken by the
research assistant. Medical records were reviewed to
abstract data needed for questionnaire.
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Specimen processing
Up to two throat and/or nasal swabs were collected
by on-site personnel using Dacron respiratory swabs
(MicroTest viral transport media (VTM), Remel, Inc.,
Lenexa, KS, USA). Swabs were immediately placed into
the VTM and broken off so that the tip remained in the
media. VTM were maintained on ice or refrigerated at
4°C (2–8°C) during processing and stored within 60 mi-
nutes at −70°C. Specimens were stored locally at −70°C
until shipped on dry ice to NHRC for viral culture and
molecular diagnostic processing. Shipping occurred on a
weekly or biweekly basis (not to exceed 1 month) de-
pending on season and FRI rates at respective training
sites. The NHRC laboratory is accredited by the College
of American Pathologists.
Upon arrival at NHRC, all specimens underwent mo-
lecular testing (polymerase chain reaction [PCR]) for a
number of respiratory pathogens, including adenovirus
and influenza A. Viral culture was performed on 20% of
randomly selected specimens that were PCR positive for
adenovirus and on all of the specimens that were PCR
negative for adenovirus. Viral culture was performed
using two different cell lines: primary monkey kidney
cell line (either rhesus or cynomolgus) for influenza and
an A549 cell line for adenovirus. Influenza-positive iso-
lates were typed using hemagglutination inhibition, and
adenovirus isolates were typed using microneutralization
techniques [15,16]. Viral culture was used to test for in-
fluenza A and B and other FRI pathogens (respiratory
syncytial virus, and parainfluenza viruses 1 and 3).
Data handling
The main outcome variables were laboratory-confirmed
influenza or adenovirus, defined as having any specimen
positive for influenza or adenovirus using PCR or culture.
Adenovirus and influenza A results were determined by
PCR or culture, and influenza B was determined by cul-
ture alone. The main outcome variable was categorized
into a three-level variable based on FRI laboratory deter-
mination: adenovirus positive, influenza positive, or other
FRI (negative for adenovirus and influenza). Categorical
variables were constructed from continuous clinical vari-
ables based on clinical definitions. Acute onset was de-
fined as ≤3 days since symptom onset. Fever was defined
as temperature ≥38.0°C. Those who were afebrile were en-
rolled as provider-diagnosed pneumonia cases. Assuming
influenza vaccine protection takes 14 days to develop, the
influenza-vaccinated group was defined as those vacci-
nated longer than 14 days prior to testing. Data from the
2009 H1N1 pandemic were included in the analysis.
Statistical analysis
Statistical analysis was performed using SAS software, ver-
sion 9.2 (SAS Institute Inc., Cary, NC, USA). Frequencies
and descriptive statistics were performed. Mean and
standard deviation were reported for normally distrib-
uted variables, and median and range were reported
for non-normally distributed variables. A multivariate
polychotomous logistic regression model was devel-
oped to model the probability of laboratory-confirmed
adenovirus, laboratory-confirmed influenza, and other
FRI against clinical and demographic predictors (age,
sex, acute onset, fever, pneumonia diagnosis, sore
throat, cough, shortness of breath, nasal congestion,
headache, conjunctivitis, body aches, nausea/vomiting,
asthma, smoking history, influenza vaccination status,
training week, and enrollment site). Colinearity diag-
nostics were done to assess confounding between
predictor variables. First clinic visit and cigarette
pack-years were not incorporated in the model be-
cause of the possibility of collinearity with acute onset
and smoking.
Manual stepwise model-building strategy was used to
develop the model that included all variables signifi-
cantly associated with the main outcome variables. Pre-
dictors were included in the model one at a time and
removed if not significant at p <0.05. Asthma was the
only predictor that fell out of the model. Parameter esti-
mates and significance levels were reviewed during
model building to assess the relative importance of each
variable. Adjusted odds ratios (ORs) and confidence in-
tervals (CIs) were reported for each multivariate logistic
regression model. Variance inflation factor and tolerance
values were evaluated to assess multicollinearity and
model fitness. All variables were considered statistically
significant at p <0.05.
Variables demonstrating associations with laboratory-
confirmed adenovirus and influenza (ie, the predictors of
influenza and adenovirus) in the reduced multivariate
model were incorporated into various clinical combina-
tions. Sensitivity, specificity, positive predictive value
(PPV), and negative predictive value were calculated for
individual predictors and various clinical combinations
of predictors in an effort to model these as clinical diag-




Among 21,570 FRI cases sampled between November
2004 and October 2009, 63.6% were laboratory-confirmed
adenovirus cases and 6.7% were laboratory-confirmed in-
fluenza cases. Trainees presented to the clinic 3 days after
self-reported onset of symptoms (range 1–90). For 68.0%
of trainees, it was their first illness-related clinic visit.
Subjects were predominantly young men (86.8% men;
mean years 20.8 ± 3.8) from Fort Jackson (18.8%), Great
Lakes (17.1%), Fort Leonard Wood (16.3%), MCRD San
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Table 1 Demographic and clinical characteristics of military trainees according to etiology of febrile respiratory illness
(2004–2009)
Variable by FRI outcome Total study population Adenovirus Influenza Other
(n = 21,570) (n = 13,725) (n = 1,435) (n = 6,410)
Continuous variablese valuea valuea valuea valuea
Age (years) 20.8 (3.8) 20.5 (3.7) 21.2 (3.7) 21.2 (4.2)
Symptom duration (days) 3.0 (1–90) 3.0 (1–90) 3.0 (1–52) 3.0 (1–84)
Temperature (°C) 38.2 (1.5) 38.4 (1.5) 38.4 (1.3) 38.2 (1.5)
Smoking history (pack-years) 1.0 (0–99) 1.0 (0–99) 1.0 (0–72) 0.5 (0–40)
Days since vaccinationb (Influenza) 31.0 (0–365) 33.0 (0–363) 10.0 (0–351) 29.0 (0–365)
Training week 4.7 (3.0) 5.0 (2.6) 3.2 (3.2) 4.7 (3.8)
Categorical variablese n (%) n (%) n (%) n (%)
Training season
Fall 5,088 (23.6) 3,423 (24.9) 227 (15.8) 1,438 (22.4)
Spring 4,675 (21.7) 3,144 (22.9) 78 (5.4) 1,453 (22.7)
Summer 6,574 (30.5) 4,501 (32.8) 403 (28.1) 1,670 (26.1)
Winter 5,233 (24.3) 2,657 (19.4) 727 (50.7) 1,849 (28.8)
Sex
Female 2,846 (13.2) 1,568 (11.4) 252 (17.6) 1,026 (16.0)
Male 18,724 (86.8) 12,157 (88.6) 1,183 (82.4) 5,384 (84.0)
Acute onset
≤3 days 12,750 (59.1) 7,623 (55.5) 1,060 (73.9) 4,067 (63.4)
>3 days 8,820 (40.9) 6,102 (44.5) 375 (26.1) 2,343 (36.6)
Fever
≥38.0°C 17,917 (83.0) 11,945 (87.0) 1,232 (85.9) 4,740 (73.9)
<38.0°C 3,653 (17.0) 1,780 (13.0) 203 (14.1) 1,670 (26.1)
First visit
Yes 14,659 (68.0) 8,867 (64.6) 1,065 (74.2) 4,727 (73.7)
No 6,911 (32.0) 4,858 (35.4) 370 (25.8) 1,683 (26.2)
Pneumoniac
Yes 2,882 (13.4) 1,624 (11.8) 107 (7.5) 1,151 (18.0)
No 18,688 (86.6) 12,101 (88.1) 1,328 (92.5) 5,259 (82.0)
Sore throat
Yes 19,174 (88.9) 12,771 (93.0) 1,168 (81.3) 5,235 (81.7)
No 2,396 (11.1) 954 (7.0) 267 (18.6) 1,175 (18.3)
Cough
Yes 19,249 (89.2) 12,559 (91.5) 1,410 (98.3) 5,280 (82.4)
No 2,321 (10.7) 1,166 (8.5) 25 (1.7) 1,130 (17.6)
Shortness of breath
Yes 8,045 (37.3) 5,010 (36.5) 545 (38.0) 2,490 (38.8)
No 13,525 (62.7) 8,715 (63.5) 890 (62.0) 3,920 (61.2)
Nasal congestion
Yes 17242 (80.0) 11223 (81.8) 1153 (80.3) 4,866 (75.9)
No 4328 (20.1) 2502 (18.2) 282 (19.7) 1,544 (24.1)
Headache
Yes 17,890 (82.9) 1,1571 (84.3) 1,204 (84.0) 5,115 (79.8)
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Diego (19.0%), Fort Benning (13.3%), Lackland (7.5%),
MCRD Parris Island (8.7%), and Cape May (3.2%). Most
subjects were febrile (83.0%) and had a cough (89.2%)
and/or sore throat (88.9%) because of study inclusion
criteria. Adenovirus-confirmed cases had a higher per-
centage with a sore throat compared with influenza
cases (adenovirus = 93%, influenza = 81.3%; P < .0001).
Conversely, influenza-positive cases had a higher per-
centage with a cough compared with adenovirus-positive
cases (influenza = 98.3%, adenovirus = 91.5%; P < .0001).
Subject characteristics are reported in Table 1.
Multivariate analysis
Regression modeling revealed associations with laboratory-
confirmed adenovirus and clinical predictors (adjusted OR
and 95% CI reported): sore throat (OR, 2.94; 95% CI, 2.66–
3.25, cough (OR, 2.33; 95% CI, 2.11–2.57), fever (OR, 2.07;
95% CI, 1.90–2.26), nausea/vomiting (OR, 1.19; 95% CI,
1.11–1.27), and nasal congestion (OR, 1.12; 95% CI, 1.03–
1.22). Regression modeling of laboratory-confirmed influ-
enza showed significant associations with cough (OR,
13.85; 95% CI, 9.14–20.97), fever (OR, 1.99; 95% CI, 1.66–
2.38), acute onset (OR, 1.46; 95% CI, 1.26–1.68), and body
aches (OR, 1.31; 95% CI, 1.13–1.53). Sore throat, nasal
congestion, and nausea/vomiting were associated with
laboratory-confirmed adenovirus but not with influenza,
while acute onset of illness (≤3 days) and body aches were
associated with laboratory-confirmed influenza but not
with adenovirus. Fever and cough were significantly associ-
ated with both adenovirus and influenza. Asthma fell out of
the model all together.
Analysis of demographic factors revealed interesting
results. Female sex was a protective factor for adenovirus
infection (OR, 0.72; 95% CI, 0.66–0.80) but was not as-
sociated with influenza. Being a smoker before training
was protective for both adenovirus and influenza (OR,
0.92; 95% CI, 0.86–0.99) and OR, 0.77; 95% CI, 0.67–
0.88, respectively). Adenovirus was seen year-round
and associated with all training seasons, with a pro-
tective effect seen during the winter season. However,
winter training was significantly associated with influ-
enza, with a protective effect seen during other sea-
sons. Distribution of study cases by seasons and years
is illustrated in the Figure 1.
Furthermore, influenza was associated with the first
2 weeks of training (OR, 1.82, 95% CI, 1.50–2.21).
Table 1 Demographic and clinical characteristics of military trainees according to etiology of febrile respiratory illness
(2004–2009) (Continued)
No 3680 (17.1) 2154 (15.7) 231 (16.0) 1,295 (20.2)
Conjunctivitis
Yes 1,901 (8.8) 1,224 (8.9) 76 (5.3) 601 (9.4)
No 19,669 (91.2) 12,501 (91.1) 1,359 (94.7) 5,809 (90.6)
Body aches
Yes 15,318 (71.0) 9,804 (71.4) 1,073 (74.8) 4,441 (69.3)
No 6,252 (29.0) 3,921 (28.6) 362 (25.2) 1,969 (30.7)
Nausea/vomiting
Yes 10,757 (49.9) 7,135 (51.9) 701 (48.9) 2,921 (45.6)
No 10,813 (50.1) 6,590 (48.1) 734 (51.1) 3,489 (54.4)
Asthma
Yes 1,153 (5.3) 670 (4.9) 85 (5.9) 398 (6.2)
No 20,417 (94.7) 13,055 (95.1) 1,350 (94.1) 6,012 (93.8)
Smoker
Yes 6,942 (32.2) 4,360 (31.8) 406 (28.3) 2,176 (33.9)
No 14,628 (67.8) 9,365 (68.2) 1,029 (71.7) 4,234 (66.1)
Vaccinated (influenza)d
Yes 14,005 (65.0) 8,685 (63.3) 888 (61.9) 4,432 (69.1)
No 7,565 (35.0) 5,040 (36.7) 547 (38.1) 1,978 (30.9)
aContinuous variable values reported as “mean (standard deviation)” if symmetric variable or “median (min–max range)” if non-symmetric.
bMissing data due to seasonal vaccine schedule—Total population, n = 6,067; Adenovirus group, n = 3,670; Influenza group, n = 695; Other group, n = 1,702.
Vaccination days were limited to vaccination within the last year.
cAll pneumonias were provider diagnosed.
dIndividuals were considered vaccinated if their vaccination date was ≥14 days.
ep-value determination - χ2 was used for categorical variables; Kruskal Wallis test or one-way ANOVA for continuous variables. All variable were significant at
P < .0001 except for shortness of breath (P =0.0300), body aches (P = 0.002), and asthma (P = 0.0002).
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Adjusted OR 95% CI
Sore throat 2.94 2.66 - 3.25
Cough 2.33 2.11 - 2.57
Fever ≥38 C 2.07 1.90 - 2.26
Summer 2.01 1.81 - 2.22
Training weeks 5 & 6 1.91 1.74 - 2.10
Fall 1.63 1.48 - 1.80
Training weeks 3 & 4 1.61 1.47 - 1.76
Spring 1.43 1.30 - 1.58
Influenza vaccinated 1.28 1.18 - 1.39
Nausea 1.19 1.11 - 1.27
Nasal congestion 1.12 1.03 - 1.22
Headache 1.06 0.97 - 1.16
Body aches 1.01 0.93 - 1.09
Smoker 0.92 0.86 - 0.99
Conjunctivitis 0.89 0.80 - 1.00
Pneumonia 0.82 0.73 - 0.91
Shortness of breath 0.80 0.74 - 0.86
Female sex 0.72 0.66 - 0.80
Acute onset ≤3 days 0.72 0.67 - 0.78
Training weeks 0-2 0.34 0.31 - 0.38
Adjusted odds ratio (95% confidence interval)
Factors associated with adenovirus 
Figure 2 Results of multivariate analysis comparing demographic and clinical factors of military trainees with illness due to adenovirus.
Training week was converted to a categorical variable for multivariate analysis (reference category = weeks 7+). Winter was used as the reference
category for training season.
Figure 1 Distribution of laboratory-confirmed influenza and adenovirus cases among military basic trainees, 2004–2009. Histogram
depicts all laboratory-confirmed influenza and adenovirus cases in the study population, along with those that were negative for influenza and
adenovirus (“other” category), by season and year. Percentage of subjects who were influenza positive and adenovirus positive is also depicted.
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Adenovirus was associated with weeks 3 and 4 of train-
ing (OR, 1.61; 95% CI, 1.47–1.76), these odds increased
during training weeks 5 and 6 (OR, 1.91; 95% CI, 1.74–
2.10), with no association seen with influenza during
training weeks 3–6. Clinical and demographic factors as-
sociated with the development of laboratory-confirmed
adenovirus and influenza, as determined by multivariate
polychotomous logistic regression analysis, are shown in
Figures 2 and 3.
Table 2 displays the performance of clinical diagnostic
tests constructed from combinations of predictors for
adenovirus. The highest specificity (92.4%) and PPV
(81.7%) were noted for a combination of four criteria
(sore throat, fever, training weeks 3–6, summer season),
but the sensitivity was low (19.5%). The combination of
three criteria (sore throat, cough, and fever) yielded both
high sensitivity (74.4%) and PPV (71.2%) but had mar-
ginal specificity (47.3%). Table 3 displays the results of
clinical diagnostic tests constructed from combina-
tions of predictors for influenza. The combination of
four criteria (cough, training week 0–2, winter season,
and fever) had the highest specificity (97.0%) and PPV
(39.4%) but had a sensitivity of 26.9%. The combin-
ation of two criteria (cough and fever) showed the highest
sensitivity (84.3%), with a specificity of 27.1% and a PPV
of 7.6%.
Discussion
Adenovirus and influenza infections are the leading cause
of FRI outbreaks among military trainees at RTCs. This
study compared the predictive values of demographic and
clinical factors for laboratory-confirmed adenovirus and
laboratory-confirmed influenza from 2004 to 2009 among
military trainees. The results of this study may help
clinicians distinguish an influenza or adenovirus infection
from an illness caused by other FRI, based on clinical
symptoms and demographic factors. Distinguishing clin-
ical and demographic factors may aid clinicians with dif-
ferential diagnosis when laboratory confirmation is not
available and allow for appropriate dissemination of anti-
viral medications for influenza.
Few studies have examined factors associated with
specific viral pathogens causing FRI among military pop-
ulations. A study by McNeill and colleagues investigated
the clinical presentation of influenza, adenovirus, and
other pathogens causing FRI among military members.
They found that overall viral pathogens presented as clin-
ically indistinguishable from one another [17]. Conversely,
Adjusted OR 95% CI
Cough 13.85 9.14 - 20.97
Fever ≥38 C 1.99 1.66 - 2.38
Training weeks 0-2 1.82 1.50 - 2.21
Acute onset ≤3 days 1.46 1.26 - 1.68
Body aches 1.31 1.13 - 1.53
Training weeks 5 & 6 1.22 0.98 - 1.52
Headache 1.15 0.96 - 1.37
Nausea/vomiting 1.10 0.97 - 1.26
Training weeks 3 & 4 1.09 0.88 - 1.35
Nasal congestion 1.09 0.93 - 1.28
Female sex 1.01 0.85 - 1.20
Shortness of breath 0.94 0.82 - 1.08
Smoker 0.77 0.67 - 0.88
Sore throat 0.71 0.60 - 0.85
Conjunctivitis 0.57 0.44 - 0.75
Pneumonia 0.45 0.36 - 0.58
Summer 0.44 0.37 - 0.52
Influenza vaccinated 0.33 0.28 - 0.39
Fall 0.31 0.26 - 0.38
Spring 0.14 0.11 - 0.18
Adjusted odds ratio (95% confidence interval)
Factors associated with influenza
Figure 3 Results of multivariate analysis comparing demographic and clinical factors of military trainees with illness due to influenza.
Training week was converted to a categorical variable for multivariate analysis (reference category = weeks 7+). Winter was used as the reference
category for training season.
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this present study found several clinical symptoms to be
independently associated with adenovirus (sore throat,
nausea/vomiting, and nasal congestion) and influenza
(acute onset and body aches). Cough and fever were
associated with both adenovirus and influenza. How-
ever, although cough and fever were associated with
both pathogens, recruits with a cough were signifi-
cantly more likely to be positive for influenza (OR,
13.6; 95% CI, 9.03–20.48) than adenovirus (OR, 2.32;
95% CI, 2.07–2.59). This is consistent with other stud-
ies that have reported fever and cough as highly pre-
dictive of influenza infections, and with the Centers
Table 2 Clinical diagnostic tests based on main predictor variables associated with adenovirus among military trainees
with febrile respiratory illness
Clinical predictor(s) SN (%) (95% CI) SP (%) (95% CI) PPV (%) (95% CI) NPV (%) (95% CI)
Sore throat 93.0 (92–93) 18.4 (17–19) 66.6 (65–67) 60.2 (58–62)
Cough 91.5 (91–91) 14.7 (13–15) 65.2 (64–65) 49.8 (47–51)
Fever 87.0 (86–87) 23.9 (22–24) 66.7 (65–67) 51.3 (49–52)
Summer 32.8 (32–33) 73.4 (72–74) 68.5 (67–69) 38.3 (37–39)
Training week 5 & 6 30.2 (29–30) 83.5 (82–84) 76.2 (75–77) 40.6 (39–41)
Fall 24.9 (24–25) 78.8 (77–79) 67.3 (65–68) 37.5 (36–38)
Training week 3 & 4 38.8 (38–39) 76.9 (75–77) 74.6 (73–75) 41.8 (41–42)
Training week 3–6 70.0 (69–70) 59.4 (58–60) 75.3 (74–76) 52.9 (51–53)
Spring 22.9 (22–23) 80.5 (79–81) 67.3 (65–68) 37.4 (36–38)
Sore throat + cough 85.3 (84–85) 30.6 (29–31) 68.3 (67–68) 54.4 (52–55)
Sore throat + fever 81.2 (80–81) 36.7 (35–37) 69.2 (68–69) 52.7 (51–54)
Sore throat + cough + fever 74.4 (73–75) 47.3 (46–48) 71.2 (70–71) 51.4 (50–52)
Sore throat + cough + fever + summer 24.2 (23–24) 86.3 (85–87) 75.5 (74–76) 39.4 (38–40)
Sore throat + cough + fever + training week 3–6 52.8 (51–53) 79.0 (78–79) 81.5 (80–82) 48.9 (48–49)
Sore throat + fever + summer 26.7 (25–27) 83.0 (82–83) 73.4 (72–74) 39.3 (38–40)
Sore throat + fever + training week 3–6 56.7 (55–57) 75.4 (74–76) 80.1 (79–80) 49.9 (48–50)
Sore throat + fever + training week 3–6 + summer 19.5 (18–20) 92.4 (91–92) 81.7 (80–82) 39.6 (38–40)
NOTE. Predictor variables were added to diagnostic test based on descending order of significance with outcome variable (influenza) on multivariate logistic
regression results. Adenovirus was compared with FRI other (non-adenovirus confirmed, non-influenza confirmed) and influenza confirmed.
CI, confidence interval, calculated with binomial expansion; NPV, negative predictive value; PPV, positive predictive value; SN, sensitivity; SP, specificity.
Table 3 Clinical diagnostic tests based on main predictor variables associated with influenza among military trainees
with febrile respiratory illness
Clinical predictor(s) SN (%) (95% CI) SP (%) (95% CI) PPV (%) (95% CI) NPV (%) (95% CI)
Cough 98.3 (97–98) 11.4 (10–11) 7.3 (6–7) 98.9 (98–99)
Fever 85.9 (83–87) 17.1 (16–17) 6.9 (6–7) 94.4 (93–95)
Training week 0–2 54.0 (51–56) 84.0 (83–84) 19.4 (18–20) 96.2 (95–96)
Acute onset 73.9 (71–76) 41.9 (41–42) 8.3 (7–8) 95.7 (95–96)
Body aches 74.8 (72–77) 29.3 (28–29) 7.0 (6–7) 94.2 (93–94)
Winter 50.7 (48–53) 77.6 (77–78) 13.9 (12–14) 95.7 (95–95)
Cough + fever 84.3 (82–86) 27.1 (26–27) 7.6 (7–8) 96.0 (95–96)
Cough + training week 0–2 53.4 (50–56) 85.9 (85–86) 21.3 (19–22) 96.3 (96–96)
Cough + training week 0–2 + fever 43.7 (41–46) 89.4 (88–89) 22.7 (21–24) 95.7 (95–95)
Cough + training week 0–2 + fever + acute onset 33.2 (30–35) 93.9 (93–94) 27.9 (25–30) 95.2 (94–95)
Training week 0–2 + winter 9.3 (7–10) 95.4 (95–95) 12.6 (10–14) 93.7 (93–93)
Cough + training week 0–2 + winter 33.9 (31–36) 95.8 (95–96) 36.3 (33–38) 95.3 (95–95)
Cough + training week 0–2 + winter + fever 26.9 (24–29) 97.0 (96–97) 39.4 (36–42) 94.9 (94–95)
NOTE. Predictor variables were added to diagnostic test based on descending order of significance with outcome variable (influenza) on multivariate logistic
regression results. Influenza was compared with other FRI (non-adenovirus confirmed, non-influenza confirmed) and adenovirus confirmed.
CI, confidence interval, calculated with binomial expansion; NPV, negative predictive value; PPV, positive predictive value; SN, sensitivity; SP, specificity.
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for Disease Control and Prevention definition for
influenza-like illness [6,18,19].
The clinical presentation of adenovirus illness de-
scribed in this paper is similar to other military studies
[17,20]. A study conducted by Brosch et al. looking at
clinical predictors for adenovirus 14 showed that the
majority of adenovirus cases had cough and fever [18].
McNeill et al. found similar results [17,20]. Several other
studies have seen an association between adenovirus in-
fection and either abdominal pain or nausea [5,17,21],
consistent with the present study. A recent study evalu-
ating the clinical presentation of military personnel
presenting with FRI found that influenza-positive cases
were more likely to present with a runny nose, chills,
and ocular symptoms than were other FRI cases, which
were more likely to present with a sore throat and
nausea/vomiting [8]. Interestingly, our study found sore
throat and nausea/vomiting to be solely associated with
adenovirus.
In this study, demographic factors associated with
adenoviral infections included male sex, smoking, train-
ing week (weeks 5 and 6) and training season (spring,
summer, and fall months). The protective association
seen between smoking and both adenovirus and influ-
enza infections appears counterintuitive. Although the
literature is conflicting, a protective effect has previously
been seen with adenovirus infections [22]. However, the
majority of studies published have shown smoking is a
risk factor for FRI [21,23,24]. That said, all military
training facilities are smoke free and the protective
effect seen among adenovirus-positive individuals may
be a result of more frequent adenovirus infections seen
among smokers in general, hence a natural immunity
may have been present prior to military enlistment [25].
Our results substantiate previous studies that reported
adenovirus-associated illness in training weeks 3–6 and
the protective effect of female sex [11,12,26,27]. We
found that influenza was more likely to occur within the
first 2 weeks of training and during the winter season,
whereas adenovirus was more likely to occur during
weeks 3–6 of training and during the spring, summer,
and fall seasons. Training week and seasons are poten-
tial tools that clinicians can use to aid in differential
diagnosis of FRI among military trainees. Clinical pre-
dictors found in this study can aid with quarantine
procedures during and FRI outbreak thus reducing
the spread of disease and reducing costs to the US
government.
Conclusions
After a 12-year absence, second-generation oral vaccines
for adenovirus types 4 and 7 resumed distribution at
RTCs in October 2011. Since that time, rates of FRI
and adenoviral morbidity have decreased substantially.
Although there is hope that the cross-protective effect of
the vaccines will be seen among the non–vaccine-tar-
geted adenovirus serotypes, it will be important to track
the response of different serotypes to the vaccines. The
body of literature could be enhanced by conducting
further studies examining clinical and demographic
characteristics of adenovirus subtypes causing FRI at
RTCs, with a comparative analysis pre- and post-vaccine
distribution.
Although our study included a robust sample size and
laboratory-confirmed illness, it predominately consisted
of young men in a military training environment. The
epidemiology and pathogens causing respiratory illness
among military recruits is often unique and different
from that of the civilian setting. As a result, these finding
may not be generalizable to the civilian population.
Lastly, clinical predictors of influenza and adenovirus
may differ among viral subtypes. Further studies are
needed to explore the clinical presentation among sub-
types of viral pathogens.
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